Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients
Clinical trial NCT05887466 · COMPLETED
Trial details
- NCT number
- NCT05887466
- Sponsor
- S.Biomedics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-09
- Primary completion
- 2025-12-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.